Jairoun Ammar Abdulrahman, Al-Himyari Sabaa Saleh, Shahwan Moyad, Al Ani Mina, Habeb Mustafa, Jairoun Maimona, Zyoud Sa'ed H, Alkhanani Mustfa Faisal, Alhasani Reem Hasaballah, Hakami Alqassem Y, Ainousah Bayan A, Alshehri Fahad S, Alorfi Nasser M, Suliman Abdulhaq
Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates.
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University of Science Malaysia (USM), Pulau Pinang, Malaysia.
Front Pharmacol. 2023 Sep 5;14:1237717. doi: 10.3389/fphar.2023.1237717. eCollection 2023.
Community pharmacists play an intermediary role between prescribing physicians and patients in the United Arab Emirates (UAE) and thus are responsible for ensuring that patients receive optimal cardiovascular disease (CVD) pharmaceutical care. we used a cross-sectional design to assess the perceptions and practices of community pharmacists concerning pharmaceutical care for patients with CVD. A trained researcher visited randomly selected community pharmacies and used a structured questionnaire to conduct in-person interviews with pharmacists. The questionnaire collected demographic data and information on perceptions and practices regarding CVD pharmaceutical care. Five hundred and fifty-one participants were recruited. The average participant age (mean ± SD) was 35 ± 2.7 years. The average perception score regarding CVD prevention and management was 75.6% (95% confidence interval [CI] 77.1%-74.2%), and the average practice score for CVD prevention and management was 87.1% (95% CI 76.5%-79.6%). Bivariate analysis revealed that gender ( = 0.001), education level ( < 0.001), pharmacy position ( = 0.004), work experience ( < 0.001), number of patients served per day ( < 0.001) and being trained on CVD prevention and management ( < 0.001) were significantly associated with perceptions about the prevention and management of CVD. Better practice scores were seen among older participants (OR 1.01; 95% CI 1-1.019), postgraduates (OR 1.77; 95% CI 1.66-1.89), workers at chain pharmacies (OR 1.24; 95% CI 1.11-1.39), pharmacists in charge (OR 1.22; 95% CI 1.01-1.47), pharmacists with >10 years of experience (OR 11.3; 95% CI 6.01-15.62), pharmacists with 6-10 years of experience (OR 4.42; 95% CI 3.90-5) and pharmacists trained on CVD prevention and management (OR 1.29; 95% CI 1.15-1.46). Pharmacy practitioners working in community pharmacies in the UAE actively engage in delivering pharmaceutical care to patients, playing a role in CVD management and prevention. However, they showed low levels of involvement in other healthcare services, specifically in screening and measuring patients' weight, glucose levels, and blood pressure, monitoring treatment responses, maintaining medical records, and reviewing medication refill histories. Activities such as educating patients, providing medication counseling, offering support for treatment adherence, and fostering collaborative relationships with other healthcare providers should be encouraged among UAE community pharmacists to ensure the provision of high-quality patient care.
在阿拉伯联合酋长国（阿联酋），社区药剂师在开处方的医生和患者之间发挥着中介作用，因此有责任确保患者获得最佳的心血管疾病（CVD）药物治疗服务。我们采用横断面设计来评估社区药剂师对CVD患者药物治疗服务的看法和实践。一名经过培训的研究人员走访了随机选择的社区药房，并使用结构化问卷对药剂师进行面对面访谈。该问卷收集了人口统计学数据以及有关CVD药物治疗服务的看法和实践的信息。共招募了551名参与者。参与者的平均年龄（均值±标准差）为35±2.7岁。关于CVD预防和管理的平均认知得分是75.6%（95%置信区间[CI]77.1%-74.2%），CVD预防和管理的平均实践得分是87.1%（95%CI76.5%-79.6%）。双变量分析显示，性别（P = 0.001）、教育水平（P < 0.001）、药房职位（P = 0.004）、工作经验（P < 0.001）、每天服务的患者数量（P < 0.001）以及接受过CVD预防和管理培训（P < 0.001）与对CVD预防和管理的看法显著相关。年龄较大的参与者（比值比[OR]1.01；95%CI1-1.019）、研究生（OR1.77；95%CI1.66-1.89）、连锁药房的工作人员（OR1.24；95%CI1.11-1.39）、主管药剂师（OR1.22；95%CI1.01-1.47）、有超过10年经验的药剂师（OR11.3；95%CI6.01-15.62）、有6-10年经验的药剂师（OR4.42；95%CI3.90-5）以及接受过CVD预防和管理培训的药剂师（OR1.29；95%CI1.15-1.46）的实践得分更高。在阿联酋社区药房工作的药剂师积极参与为患者提供药物治疗服务，在CVD管理和预防中发挥作用。然而，他们在其他医疗服务方面的参与度较低，特别是在筛查和测量患者体重、血糖水平和血压、监测治疗反应、维护病历以及审查药物 refill 历史记录方面。应鼓励阿联酋社区药剂师开展诸如教育患者、提供用药咨询、支持治疗依从性以及与其他医疗服务提供者建立合作关系等活动，以确保提供高质量的患者护理。
